Managing patients with co-existing heart failure and atrial fibrillation remains a complex clinical challenge for physicians. Recent research underscores the clinical effectiveness of AF ablation heart failure procedures compared to traditional medical management. A long-term retrospective study highlights how catheter ablation significantly enhances survival rates and cardiac performance over a five-year period.

Long-term Survival and Mortality Benefits

The study analyzed 328 patients. Specifically, the ablation group experienced significantly higher five-year survival rates compared to medical therapy. Furthermore, the radiofrequency group had lower cardiovascular mortality. Consequently, this intervention serves as an independent protective factor against all-cause mortality. Therefore, clinicians should consider ablation early in the treatment pathway for eligible patients. Notably, multivariate analysis confirmed that radiofrequency ablation independently predicts better survival outcomes.

Improving Cardiac Function and LVEF

Beyond survival, the ablation group showed a remarkable increase in left ventricular ejection fraction (LVEF). At 12 months post-procedure, the LVEF in the ablation group rose by 8.3%. In contrast, the medical therapy group only saw a 0.4% increase. Moreover, over 70% of ablation patients achieved a clinically significant LVEF improvement. These functional gains directly contribute to a better quality of life and improved exercise tolerance. Identifying AF ablation heart failure as a primary strategy can reverse cardiac remodeling in many patients.

Reduced Hospitalization and Recurrence

The ablation group saw significantly fewer heart failure hospitalizations. Furthermore, the 60-month AF-free rate was nearly 69% in the ablation group. However, the medical group only achieved a 21.5% rate. Maintaining sinus rhythm through ablation provides long-term stability and reduces the risk of future cardiac events. This reduction in hospital visits alleviates the burden on both patients and healthcare systems. Additionally, patients with paroxysmal AF showed unique baseline characteristics that require tailored clinical attention.

Frequently Asked Questions

Is ablation safe for all heart failure patients with AF?

While generally safe, patient selection remains critical. Factors such as AF duration and ventricular rate influence the final outcomes. Current clinical guidelines suggest prioritizing patients who remain symptomatic despite optimal medical therapy.

How much does LVEF typically improve after ablation?

In this study, the ablation group experienced a mean LVEF increase of 8.3%. Moreover, nearly three-quarters of the patients saw an increase of 5% or more, indicating robust cardiac recovery compared to conservative medical management.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

He L et al. Long-term Retrospective Study on Survival and Cardiac Function Improvement in Heart Failure Patients with Atrial Fibrillation Treated With Radiofrequency Ablation. Kardiologiia. 2026 Feb 11. doi: 10.18087/cardio.2026.1.n3019. PMID: 41671026.

Marrouche NF et al. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med. 2018;378(5):417-427. doi:10.1056/NEJMoa1707855.

Packer DL et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1259-1274. doi:10.1001/jama.2019.2255.